作者: Jan Anderl , Heinz Faulstich , Torsten Hechler , Michael Kulke
DOI: 10.1007/978-1-62703-541-5_4
关键词:
摘要: Toxin payloads, or drugs, are the crucial components of therapeutic antibody-drug conjugates (ADCs). This review will give an introduction on requirements that make a toxic compound suitable to be used in antitumoral ADC and summarize structural mechanistic features four drug families yielded promising results preclinical clinical studies.